DK1565451T3 - Halogenthienoylcyclopropan-1-carboxylsyre-derivater - Google Patents
Halogenthienoylcyclopropan-1-carboxylsyre-derivaterInfo
- Publication number
- DK1565451T3 DK1565451T3 DK03811772T DK03811772T DK1565451T3 DK 1565451 T3 DK1565451 T3 DK 1565451T3 DK 03811772 T DK03811772 T DK 03811772T DK 03811772 T DK03811772 T DK 03811772T DK 1565451 T3 DK1565451 T3 DK 1565451T3
- Authority
- DK
- Denmark
- Prior art keywords
- branched
- linear
- alkyl
- halogenthienoylcyclopropan
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02026597A EP1424333A1 (en) | 2002-11-28 | 2002-11-28 | Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
PCT/EP2003/013244 WO2004048361A1 (en) | 2002-11-28 | 2003-11-25 | Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1565451T3 true DK1565451T3 (da) | 2007-09-10 |
Family
ID=32241303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03811772T DK1565451T3 (da) | 2002-11-28 | 2003-11-25 | Halogenthienoylcyclopropan-1-carboxylsyre-derivater |
Country Status (13)
Country | Link |
---|---|
US (1) | US20060116329A1 (da) |
EP (2) | EP1424333A1 (da) |
JP (1) | JP4522864B2 (da) |
AT (1) | ATE361921T1 (da) |
AU (1) | AU2003296596B2 (da) |
CA (1) | CA2507597A1 (da) |
CY (1) | CY1106692T1 (da) |
DE (1) | DE60313798T2 (da) |
DK (1) | DK1565451T3 (da) |
ES (1) | ES2286509T3 (da) |
PT (1) | PT1565451E (da) |
SI (1) | SI1565451T1 (da) |
WO (1) | WO2004048361A1 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1475088A1 (en) * | 2003-05-05 | 2004-11-10 | Newron Pharmaceuticals S.p.A. | Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract |
GB2402940A (en) * | 2004-08-19 | 2004-12-22 | Pfizer Ltd | Biomarkers of inflammation and/or macrophage activation |
EP1869008A1 (en) * | 2005-04-11 | 2007-12-26 | Probiodrug AG | Inhibitors of prolyl endopeptidase |
WO2012175513A1 (en) | 2011-06-20 | 2012-12-27 | Bayer Intellectual Property Gmbh | Thienylpyri(mi)dinylpyrazole |
CN104244939A (zh) * | 2012-04-05 | 2014-12-24 | Chdi基金会股份有限公司 | 犬尿氨酸-3-单加氧酶抑制剂、其药物组合物及其使用方法 |
JP2016536350A (ja) | 2013-09-26 | 2016-11-24 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | キヌレニン−3−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法 |
US9938252B2 (en) | 2013-09-26 | 2018-04-10 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
GB201322512D0 (en) | 2013-12-19 | 2014-02-05 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
GB201508857D0 (en) | 2015-05-22 | 2015-07-01 | Glaxosmithkline Ip Dev Ltd | Compounds |
GB201508864D0 (en) | 2015-05-22 | 2015-07-01 | Glaxosmithkline Ip Dev Ltd | Compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1278435B (de) * | 1965-01-19 | 1968-09-26 | Merck Ag E | Verfahren zur Herstellung von 1, 2-disubstituierten Cyclopropanderivaten |
US4022903A (en) * | 1975-06-05 | 1977-05-10 | Abbott Laboratories | α-Thienyl and α-substituted thienyl, phenyl and substituted phenyl cyclopropylomethanols useful as biodegradable insecticides and mollusicides |
US6274590B1 (en) * | 1993-01-15 | 2001-08-14 | G. D. Searle & Co. | Method of treating skin related conditions |
WO1998018760A1 (fr) * | 1996-10-30 | 1998-05-07 | Shionogi & Co., Ltd. | Inhibiteur de la liberation du glutamate et nouveaux composes |
GB9705031D0 (en) * | 1997-03-11 | 1997-04-30 | Pharmacia & Upjohn Spa | 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
-
2002
- 2002-11-28 EP EP02026597A patent/EP1424333A1/en not_active Withdrawn
-
2003
- 2003-11-25 SI SI200330828T patent/SI1565451T1/sl unknown
- 2003-11-25 AT AT03811772T patent/ATE361921T1/de not_active IP Right Cessation
- 2003-11-25 DK DK03811772T patent/DK1565451T3/da active
- 2003-11-25 AU AU2003296596A patent/AU2003296596B2/en not_active Ceased
- 2003-11-25 JP JP2004554463A patent/JP4522864B2/ja not_active Expired - Fee Related
- 2003-11-25 DE DE60313798T patent/DE60313798T2/de not_active Expired - Lifetime
- 2003-11-25 ES ES03811772T patent/ES2286509T3/es not_active Expired - Lifetime
- 2003-11-25 CA CA002507597A patent/CA2507597A1/en not_active Abandoned
- 2003-11-25 US US10/536,307 patent/US20060116329A1/en not_active Abandoned
- 2003-11-25 WO PCT/EP2003/013244 patent/WO2004048361A1/en active IP Right Grant
- 2003-11-25 PT PT03811772T patent/PT1565451E/pt unknown
- 2003-11-25 EP EP03811772A patent/EP1565451B1/en not_active Expired - Lifetime
-
2007
- 2007-07-02 CY CY20071100873T patent/CY1106692T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2507597A1 (en) | 2004-06-10 |
JP4522864B2 (ja) | 2010-08-11 |
AU2003296596B2 (en) | 2010-03-04 |
US20060116329A1 (en) | 2006-06-01 |
ATE361921T1 (de) | 2007-06-15 |
EP1565451B1 (en) | 2007-05-09 |
CY1106692T1 (el) | 2012-05-23 |
PT1565451E (pt) | 2007-08-03 |
DE60313798D1 (en) | 2007-06-21 |
JP2006509753A (ja) | 2006-03-23 |
DE60313798T2 (de) | 2008-01-24 |
SI1565451T1 (sl) | 2007-08-31 |
WO2004048361A1 (en) | 2004-06-10 |
AU2003296596A1 (en) | 2004-06-18 |
EP1424333A1 (en) | 2004-06-02 |
ES2286509T3 (es) | 2007-12-01 |
EP1565451A1 (en) | 2005-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106692T1 (el) | Παραγωγα του αλοξενοϋλ-κυκλοπροπαν-1-καρβοξυλικου οξεος | |
HN1997000027A (es) | Derivados de 6-fenil piridil - 2 amina | |
DK1442024T3 (da) | Aminobenzamidderivater som glycogensystasekinase 3 beta-inhibitorer | |
DK0931788T3 (da) | Metalloproteasehæmmere | |
DE60225671D1 (de) | Pharmazeutisch wirksame piperidinderivate | |
DK1076663T3 (da) | Funktionaliserede alkyl- og alkenylsidekædederivater af glycinamider som farnesyltransferaseinhibitorer | |
DK1424330T3 (da) | Aktivator for peroxisom proliferator-responsiv receptor delta | |
EP1490371A4 (en) | TRICYCLIC COMPOUNDS BASED ON THIOPENE AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS | |
DK1485377T3 (da) | Pyranoner egnede som ATM-inhibitorer | |
ES2177275T3 (es) | Derivados de oxadiazolina y su uso como insecticidas. | |
FI20001593A0 (fi) | Comt-entsyymiä inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia | |
DE60223904D1 (de) | Benzylaminanalogen | |
DK0753511T3 (da) | 4-indol-1-ylsmørsyrederivater, deres fremstilling og deres anvendelse som inhibitorer af alfa 1-adrenerge receptorer og testosteron-5alfa-reduktaser | |
DK1663122T3 (da) | Mundskyllesammensætninger indeholdende N-acyl-argininalkylestersalte | |
ATE201402T1 (de) | Optisch aktive thiazolidinonderivate | |
HUP0303760A2 (hu) | AZ NF-kB faktort gátló szubsztituált benzoesavszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
ES2190781T3 (es) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano. | |
ECSP045176A (es) | Derivados de 5-(piridin-3-il)-1-azabiciclo[3.2.1]octano, su preparacion y su aplicación en terapeutica | |
ATE199717T1 (de) | Benzothiophenverbindungen, ihre anwendungen und zusammensetzungen | |
DK0912573T3 (da) | Camptothecinderivater, som er isoleret fra Mappia foetida, og anvendelse deraf som syntoner for nye lægemidler og som terapeutiske midler | |
DE60113808D1 (de) | Therapeutikum oder Prophylaktikum für Lebererkrankungen, enthaltend ein Diaminotrifluorethylpyridin-Derivat | |
PE20030758A1 (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion | |
ATE284379T1 (de) | Aminderivate | |
ATE259346T1 (de) | Benflumentolderivative und ihre verwendung gegen parasitäre protozoen und trematoden | |
AR055565A1 (es) | Compuestos de aminoacidos fosfinicos a un procedimiento para su preparacion y a las composiciones farmaceuticas que los contienen |